Fej-nyaki daganatok: vizsgálatok itt: Kína
217 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleFL-261 Imaging for Cancer Diagnosis and Staging
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07510321 - 3. fázisTaking peopleDevelopment and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 170
- Run by
- West China Hospital
See details and how to joinNCT07467083 - 2. fázisTaking peopleTraditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients
- Where
- Chengdu
- Életkor
- 18 év to 65 év
- People
- 118
- Run by
- West China Hospital
See details and how to joinNCT07282483 - 2/3. fázisTaking peopleTopical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- West China Hospital
See details and how to joinNCT07353671 - 1. fázisTaking peopleGV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study
- Where
- Chengdu
- Életkor
- 18 év to 70 év
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07457281 - 2. fázisNot yet taking people in KínaNano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 52
- Run by
- Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07491783 - 3. fázisTaking peopleComparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma
- Where
- Changsha, Guangzhou, Guilin, Nanjing, Sanya
- Életkor
- 18 év to 70 év
- People
- 386
- Run by
- Sun Yat-sen University
See details and how to joinNCT07125755 - 1/2. fázisTaking peopleDCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 9
- Run by
- West China Hospital
See details and how to joinNCT07035249 - No phaseNot yet taking people in KínaImpact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 85
- Run by
- Zhujiang Hospital
See details and how to joinNCT07457099 - 2. fázisTaking peopleA Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 76
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07457346 - 2. fázisTaking peopleA Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Jinan, Shanghai
- Életkor
- 18 év to 75 év
- People
- 167
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06857279 - 2. fázisTaking peopleA Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
- Where
- Tianjin
- Életkor
- 18 év to 80 év
- People
- 268
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06208826 - 2. fázisTaking peopleIparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 27
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07447570 - No phaseTaking peoplePostoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
- Where
- Bengbu, Changchun, Changsha, Chaoyang, Chengdu, Dalian, Fuzhou, Guandong, Hangzhou, Harbin, Huzhou, Nanchang, Ningbo, Qingdao, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Xi’an
- Életkor
- 18 év to 70 év
- People
- 190
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07402525 - 3. fázisNot yet taking people in KínaSurgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 184
- Run by
- Sun Yat-sen University
See details and how to joinNCT07402538 - 1/2. fázisTaking peopleStudy of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Where
- Baoding, Beijing, Bengbu, Cangzhou, Ch’ang-ch’un, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Dalian, Fuzhou, Ganzhou, Guangzhou, Ha’erbin, Hangzhou, Hanzhong, Harbin, Hefei, Henan, Hohhot, Jiangxi, Jilin City, Jinan, Kunming, Lanzhou, Nanchang, Nanjing, Nanning, Nantong, Qingdao, Qinhuangdao, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taiyuan, Taizhou, Tianjin, Tonghua, Weifang, Wenzhou, Wuhan, Wuhu, Xiamen, Xi’an, Xuzhou, Yantai, Yibin, Yinchuan, Zhengzhou, Zhenzhou
- Életkor
- 18 év and over
- People
- 400
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT04930432 - 2. fázisNot yet taking people in KínaNeoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Hangzhou
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT07393477 - 1. fázisTaking peopleA Study of SH009 Injection in Patients With Advanced Solid Tumors.
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 150
- Run by
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
See details and how to joinNCT07390838 - 2. fázisNot yet taking people in KínaA Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 37
- Run by
- chen chao Professor
See details and how to joinNCT07379424 - 3. fázisTaking peopleSintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 104
- Run by
- Qunxing Li,MD
See details and how to joinNCT07371611 - No phaseTaking peopleComparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Qunxing Li,MD
See details and how to joinNCT07369882 - 1. fázisTaking peopleFirst in Human Study of SIM0610 in Solid Tumors
- Where
- Chongqing, Harbin, Jinan, Shanghai, Shenyang
- Életkor
- 18 év and over
- People
- 260
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07348211 - 2. fázisNot yet taking people in KínaA Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Sun Yat-sen University
See details and how to joinNCT07354984 - 2. fázisTaking peopleNimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
- Where
- Shanxi
- Életkor
- 18 év to 80 év
- People
- 10
- Run by
- Tang-Du Hospital
See details and how to joinNCT07353723 - 2. fázisTaking peopleClinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 81
- Run by
- Shanghai Institute Of Biological Products
See details and how to joinNCT06194656